Cavalry Biosciences
Founded 2021 · 17 employees on LinkedIn · 3 known investors
Cavalry Biosciences is a biopharmaceutical company focused on developing medicines that leverage the body's inherent regenerative and repair mechanisms, particularly in areas of age-related disease and tissue regeneration. The company applies translational biology and drug development expertise across multiple therapeutic areas.
Founders & leadership
Cavalry Biosciences was founded in 2021 by Jan van Deursen, PhD and Nathaniel (Ned) David, PhD.
JV
Jan van Deursen, PhDinCo-founder, Advisor
N(
Nathaniel (Ned) David, PhDin𝕏Co-founder, ChairmanNed David holds a PhD in biomedical sciences and has a background in venture investing focused on medicines. He is co-founder and Chairman of Cavalry Biosciences, a biopharmaceutical company developing therapies that harness the body's regenerative and repair mechanisms for age-related disease and tissue regeneration.
Investors · 3
Funding
SEC filings, press & company announcements- Undisclosed amountSeries BJun 2026Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Cavalry Biosciences do?
- Cavalry Biosciences is a biopharmaceutical company focused on developing medicines that leverage the body's inherent regenerative and repair mechanisms, particularly in areas of age-related disease and tissue regeneration. The company applies translational biology and drug development expertise across multiple therapeutic areas.
- Who founded Cavalry Biosciences?
- Cavalry Biosciences was founded by Jan van Deursen, PhD, Nathaniel (Ned) David, PhD in 2021.
- Who are Cavalry Biosciences's investors?
- Cavalry Biosciences's investors include Venrock, Eshelman Ventures, LLC, Mission Biocapital.